FDA authorises emergency use of "first commercial H1N1 flu test"
This article was originally published in Clinica
Executive Summary
The US FDA has granted emergency use authorisation (EUA) for Focus Diagnostics' 2009 H1N1 pandemic flu test. It is the first commercial lab test to receive an EUA for H1N1 testing, Cypress, California-based Focus claims.